- $7.53bn
- $10.41bn
- $3.48bn
- 89
- 80
- 67
- 93
Annual income statement for Match, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,391 | 2,983 | 3,189 | 3,365 | 3,479 |
Cost of Revenue | |||||
Gross Profit | 1,759 | 2,146 | 2,231 | 2,413 | 2,490 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,627 | 2,573 | 2,670 | 2,448 | 2,656 |
Operating Profit | 764 | 411 | 519 | 917 | 823 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 631 | 256 | 377 | 777 | 704 |
Provision for Income Taxes | |||||
Net Income After Taxes | 588 | 276 | 362 | 651 | 551 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 162 | 278 | 362 | 652 | 551 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 162 | 278 | 366 | 664 | 564 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.01 | 1.85 | 1.24 | 2.26 | 2.11 |